Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion

European Journal of Immunology

Volumn 41, Issue 11, 2011, Pages 3240-3252

  Renoux, Virginie M ^a   Bisig, Bettina ^a   Langers, Inge ^a   Dortu, Estelle ^a   Clémenceau, Béatrice ^b   Thiry, Marc ^a   Deroanne, Christophe ^a   Colige, Alain ^a   Boniver, Jacques ^a   Delvenne, Philippe ^a   Jacobs, Nathalie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Fc receptors; NK cells; Tumor immunity; Vaccination; Viral infection

Indexed keywords

CD16 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL INFILTRATION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; IN VITRO STUDY; MICROSCOPY; NATURAL KILLER CELL; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX DISEASE; VIRUS ENTRY; VIRUS LIKE AGENT; WART VIRUS;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL SEPARATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOPRECIPITATION; KILLER CELLS, NATURAL; MICROSCOPY, CONFOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RECEPTORS, IGG; UTERINE CERVICAL NEOPLASMS; VIRUS INTERNALIZATION;

EID: 80054887028     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141693     Document Type: Article

References (55)

1. Zur Hausen, H., Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009. 384: 260-265.
2. Castellsagué, X., de San Jose, S., Aguado, T., Louie, K. S., Bruni, L., Munoz, J., Diaz, M. et al., HPV and cervical cancer in the world, 2007 Report. Vaccine 2007. 25: C1-C230.
3. Dollard, S. C., Wilson, J. L., Demeter, L. M., Bonnez, W., Reichman, R. C., Broker, T. R. and Chow, L. T., Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. Genes Dev. 1992. 6: 1131-1142.
4. Le Cann, P., Coursaget, P., Iochmann, S. and Touze, A., Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 1994. 117: 269-274.
5. Olsson, S. E., Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O. E. et al., Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 2007. 25: 4931-4939.
6. Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmeron, J., Wheeler, C. M., Chow, S. N. et al., Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007. 369: 2161-2170.
7. Hellner, K. and Münger, K., Human papillomaviruses as therapeutic targets in human cancer. J. Clin. Oncol. 2011. 29: 1785-1794.
8. Plummer, M., Schiffman, M., Castle, P. E., Maucort-Boulch, D. and Wheeler, C. M., A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 2007. 195: 1582-1589.
9. Abramowitz, L., Benabderrahmane, D., Ravaud, P., Walker, F., Rioux, C., Jestin, C., Bouvet, E. et al., Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007. 21: 1457-1465.
10. Colonna, M., Jonjic, S. and Watzl, C., Natural killer cells: fighting viruses and much more. Nat. Immunol. 2011. 12: 107-110.
11. Waldhauer, I. and Steinle, A., NK cells and cancer immunosurveillance. Oncogene 2008. 27: 5932-5943.
12. Walzer, T., Blery, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S. et al., Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 2007. 104: 3384-3389.
13. King, A., Burrows, T. and Loke, Y. W., Human uterine natural killer cells. Nat. Immun. 1996. 15: 41-52.
14. de Saint Basile, G., Ménasché, G. and Fischer, A., Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat. Rev. Immunol. 2010. 10: 568-579.
15. Perussia, B. T. G., Jackson, A., Warner, N. L., Faust, J., Rumpold, H., Kraft, D. and Lanier, L. L., The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J. Immunol. 1984. 133: 180-189.
16. Lanier, L. L., Phillips, J. H., Hackett, J., Jr., Tutt, M. and Kumar, V., Natural killer cells: definition of a cell type rather than a function. J. Immunol. 1986. 137: 2735-2739.
17. Da Silva, D., Fausch, S., Verbeek, J. and Kast, W., Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. J. Immunol. 2007. 178: 7587-7597.
18. Burghardt, E. and Ostor, A. G., Site and origin of squamous cervical cancer: a histomorphologic study. Obstet. Gynecol. 1983. 62: 117-127.
19. Yoshida, T., Sano, T., Kanuma, T., Owada, N., Sakurai, S., Fukuda, T. and Nakajima, T., Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer 2008. 114: 83-88.
20. Hopman, A. H., Smedts, F., Dignef, W., Ummelen, M., Sonke, G., Mravunac, M., Vooijs, G. P. et al., Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J. Pathol. 2004. 202: 23-33.
21. Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H. G. and Long, E. O., Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 2005. 202: 1001-1012.
22. Lenz, P., Day, P. M., Pang, Y. Y., Frye, S. A., Jensen, P. N., Lowy, D. R. and Schiller, J. T., Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 2001. 166: 5346-5355.
23. Bergsdorf, C., Beyer, C., Umansky, V., Werr, M. and Sapp, M., Highly efficient transport of carboxyfluorescein diacetate succinimidyl ester into COS7 cells using human papillomavirus-like particles. FEBS Lett. 2003. 536: 120-124.
24. Mercer, J. and Helenius, A., Virus entry by macropinocytosis. Nat. Cell Biol. 2009. 11: 510-520.
25. Sieczkarski, S. B. and Whittaker, G. R., Dissecting virus entry via endocytosis. J. Gen. Virol. 2002. 83: 1535-1545.
26. Bousarghin, L., Touzé, A., Sizaret, P.-Y. and Coursaget, P., Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 2003. 77: 3846-3850.
27. Bousarghin, L., Hubert, P., Franzen, E., Jacobs, N., Boniver, J. and Delvenne, P., Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J. Gen. Virol. 2005. 86: 1297-1305.
28. Joyce, J. G., Tung, J. S., Przysiecki, C. T., Cook, J. C., Lehman, E. D., Sands, J. A., Jansen, K. U. et al., The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 1999. 274: 5810-5822.
29. Kobayashi, A., Greenblatt, R. M., Anastos, K., Minkoff, H., Massad, L. S., Young, M., Levine, A. M. et al., Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004. 64: 6766-6774.
30. Textor, S., Durst, M., Jansen, L., Accardi, R., Tommasino, M., Trunk, M. J., Porgador, A. et al., Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int. J. Cancer 2008. 123: 2343-2353.
31. Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A. et al., AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 2009. 183: 6186-6197.
32. Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., Facchetti, F., Communi, D. et al., The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007. 109: 3625-3632.
33. Horvath, C. A., Boulet, G. A., Renoux, V. M., Delvenne, P. O. and Bogers, J.-P. J., Mechanisms of cell entry by human papillomaviruses: an overview. Virol. J. 2010. 7: 11.
34. Ladwein, M. and Rottner, K., On the Rho'd: the regulation of membrane protrusions by Rho-GTPases. FEBS Lett. 2008. 582: 2066-2074.
35. Jarahian, M., Watzl, C., Fournier, P., Arnold, A., Djandji, D., Zahedi, S., Cerwenka, A. et al., Activation of natural killer cells by Newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 2009. 83: 8108-8121.
36. Da Silva, D. M., Velders, M. P., Nieland(4), J. D., Schiller, J. T., Nickoloff, B. J. and Kast, W. M., Physical interaction of human papillomavirus virus-like particles with immune cells. Int. Immunol. 2001. 13: 633-641.
37. Araki, N., Hatae, T., Furukawa, A. and Swanson, J. A., Phosphoinositide-3-kinase-independent contractile activities associated with Fcgamma-receptor-mediated phagocytosis and macropinocytosis in macrophages. J. Cell Sci. 2003. 116: 247-257.
38. Wu, Y., Wu, W., Wong, W. M., Ward, E., Thrasher, A. J., Goldblatt, D., Osman, M. et al., Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis. J. Immunol. 2009. 183: 5622-5629.
39. Tewary, P., Yang, D., de la Rosa, G., Li, Y., Finn, M. W., Krensky, A. M., Clayberger, C. et al., Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010. 116: 3465-3474.
40. Marquez, M. E., Millet, C., Stekman, H., Conesa, A., Deglesne, P. A., Toro, F., Sanctis, J. D. et al., CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells. Cell. Immunol. 2010. 264: 86-92.
41. Hervas-Stubbs, S., Rueda, P., Lopez, L. and Leclerc, C., Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 2007. 178: 2361-2369.
42. Rudolf, M. P., Fausch, S. C., Da Silva, D. M. and Kast, W. M., Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J. Immunol. 2001. 166: 5917-5924.
43. Chini, C. C., Boos, M. D., Dick, C. J., Schoon, R. A. and Leibson, P. J., Regulation of p38 mitogen-activated protein kinase during NK cell activation. Eur. J. Immunol. 2000. 30: 2791-2798.
44. Trotta, R., Puorro, K. A., Paroli, M., Azzoni, L., Abebe, B., Eisenlohr, L. C. and Perussia, B., Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J. Immunol. 1998. 161: 6648-6656.
45. Griesser, H., Sander, H., Hilfrich, R., Moser, B. and Schenck, U., Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal. Quant. Cytol. Histol. 2004. 26: 241-245.
46. Bottley, G., Watherston, O. G., Hiew, Y. L., Norrild, B., Cook, G. P. and Blair, G. E., High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells. Oncogene 2008. 27: 1794-1799.
47. Kirwan, S., Merriam, D., Barsby, N., McKinnon, A. and Burshtyn, D. N., Vaccinia virus modulation of natural killer cell function by direct infection. Virology 2006. 347: 75-87.
48. Mao, H., Tu, W., Liu, Y., Qin, G., Zheng, J., Chan, P. L., Lam, K. T. et al., Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J. Virol. 2010. 84: 4148-4157.
49. Garcia-Iglesias, T., Del Toro-Arreola, A., Albarran-Somoza, B., Del Toro-Arreola, S., Sanchez-Hernandez, P. E., Ramirez-Duenas, M. G., Balderas-Pena, L. M. et al., Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 2009. 9: 186.
50. Clemenceau, B., Congy-Jolivet, N., Gallot, G., Vivien, R., Gaschet, J., Thibault, G. and Vie, H., Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes. Blood 2006. 107: 4669-4677.
51. Hubert, P., Doyen, J., Capelle, X., Arafa, M., Renoux, V., Bisig, B., Seidel, L. et al., Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions. Am. J. Reprod. Immunol. 2010. 64: 126-136.
52. Christensen, N. D., Dillner, J., Eklund, C., Carter, J. J., Wipf, G. C., Reed, C. A., Cladel, N. M. et al., Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 1996. 223: 174-184.
53. Jacobs, N., Greimers, R., Mazzoni, A., Trebak, M., Schaaf-Lafontaine, N., Boniver, J. and Moutschen, M. P., Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3mAb. Cancer Immunol. Immunother. 1996. 42: 369-375.
54. Begon, D. Y., Delacroix, L., Vernimmen, D., Jackers, P. and Winkler, R., Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J. Biol. Chem. 2005. 280: 24428-24434.
55. Ho, T. T., Merajver, S. D., Lapiere, C. M., Nusgens, B. V. and Deroanne, C. F., RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha. J. Biol. Chem. 2008. 283: 21588-21598.